Caution in the use of the apolipoprotein E e4 allele as a predictor of healthcare costs

References

• Feder J, Komisar HL, Niefeld M. Long-Term care in the United States: an overview. Health Affairs 19(3), 40–56 (2000).
   Web of Science ®Google Scholar
• •Excellent overview of the financing of long-term care in the USA.
   Google Scholar
• Ermak G, Davies KJ. Gene expression in Alzheimer's disease. Drugs Today 38(7), 509–516 (2002).
   PubMed Web of Science ®Google Scholar
• Lovestone S. Early diagnosis and the clinical genetics of Alzheimer's disease. J. Neural. 246,69–72 (1999).
   PubMed Web of Science ®Google Scholar
• Tsuang D, Larson EB, Bowen J etal. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer's disease in a community based case series. Arch. Neural. 56,1489–1495 (1999).
   Google Scholar
• Stengard JH, Weiss KM, Sing CF. An ecological study of the association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Human Genetics 103,234–241 (1998).
   Google Scholar
• McCarron MO, Delong D and Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a metaanalysis. Neurology 53, 1308–1311 (1999).
   PubMed Web of Science ®Google Scholar
• Leung CH, Poon WS, Yu WM, Wong GK, Ng HK. Apolipoprotein e genotype and outcome in aneurismal subarachnoid hemorrhage. Struke 33(3), 548–552 (2002).
   PubMedGoogle Scholar
• Lichtman SW, Seliger G, Tycko B, Marder K. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 55 (10), 1536–1539 (2000).
   PubMed Web of Science ®Google Scholar
• McCarron MO, Muir KE, Nicoll JA eta]. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch. Neural. 57(10), 1480–1484 (2000).
   Google Scholar
• Burlinson S, Burns A, Mann D, Pickering- Brown S, Owen E Effect of apolipoprotein e status on clinical features of dementia. Int.j Geriat. Psych. 13,177–185 (1998).
   PubMed Web of Science ®Google Scholar
• Henderson A, Easteal S, Jorm AF eta]. Apolipoprotein E allele e4, dementia and cognitive decline in a population sample. Lancet346, 1387–1390 (1995).
   Google Scholar
• Farrar LA, Cupples LA, Haines JL et al Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease' a meta-analysis. APOE and Alzheimer's disease Meta-Analysis Consortium. JA/V/A 278, 1349–1356 (1997).
   Google Scholar
• Evans D, Beckett L, Field T eta]. Apolipoprotein E e4 and incidence of Alzheimer's disease in a community population of older persons. JAIVIA 277, 822–824 (1997).
   Google Scholar
• Yip AG, Brayne C, Easton D, Rubinsztein DC. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. J. Med. Genet. 39(9), 639–643 (2002).
   Google Scholar
• Guo Z, Fratiglioni L, Viitanen M eta]. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? Am. I Epidemiol 153(3), 225–231 (2001).
   Google Scholar
• Taylor DH Jr, Sloan FA. How much do person's with Alzheimer's disease cost medicare? jAm. Cellar. Soc. 48,639–646 (2000).
   Web of Science ®Google Scholar
• Taylor DH Jr, Schenkman M, Zhou J, Sloan FA. The effect of disability and comorbidity on the cost of alzheimer's disease and related dementias. j Gerontol Soc. Sci. 56(5), 285–293 (2001).
   Google Scholar
• Taylor DH Jr, Whellan D, Sloan FA. Effects of admission to a teaching hospital on cost and quality of care: evidence from medicare. N Eng Med 318(340), 293–299 (1999).
   Google Scholar
• Sloan FA, Taylor DH Jr., Picone G. Cost and outcomes of stroke and hip fracture: rising costs but better outcomes? Arn. Public Health 89(6), 935–937 (1999).
   Google Scholar
• Frisoni GB, Bianchetti A, Trabucchi M. Apolipoprotein E and the cost of Alzheimer's disease. Int. J. Cellar. Psych. 12,588–89 (1997).
   Google Scholar
• •Provides some empirical evidence tegarding the association between e4 and healthcare costs, although the cost estimates were synthetically developed/gleaned from other work and amalgamated as opposed to being based on observation of a defined population of individuals.
   Google Scholar
• Taylor DH Jr, Fillenbaum G, Burchett B, Blazer DG. Is the APOE e4 genotype associated with higher hospital costs? Am. Geriat. Psych. 11,75-82 (2003).
   Google Scholar
• •Provides empirical evidence of the association between e4 and cost that is based on observing actual cost data for a specific group of patients. Furthermore, the patients were based on a representative sample of elderly persons in a five county part of north-central North Carolina, USA.
   Google Scholar
• Sloan FA, Taylor DH Jr. Does ownership affect the cost of medicare? In: Medicare Reform: Issues ancl Answers. Andrew J Rettenmaier, Thomas R (Eds). University of Chicago Press, Chicago, USA, 99–130 (1999).
   Google Scholar
• Macdonald A, Pritchard D. Genetics, Alzheimer's disease and long-term care insurance. N. Am. Act. 5(2), 54–78 (2001).
   Google Scholar
• ••Crucial paper for those interested in theassociation between the e4 allele (and any other genetic marker) and long-term care insurance. Also has a very clear summary of the research literature concerning the association between the e4 allele and Alzheimer's disease.
   Google Scholar
• Blazer DG, Fillenbaum G, Burchett B. APOE-E4 allele and the risk of functional decline in a community sample of African—American and white older Americans. J. Gemntol Med Sri. 56(12), M785—M789 (2001).
   Google Scholar
• •Based on the same population-based sample as the cost paper in [14] . The information on e4 from this database is key since it is not based on a clinical sample that is more likely to be biased due to selection bias.
   Google Scholar
• Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH Jr. Apolipoprotein E E4 and risk of mortality in African—American and white colder community residents. Gemntologist 42 (3), 381–386 (2002).
   Google Scholar
• Galton DJ, Ferns GAA. Genetic markers to predict polygenic disease: a new problem for social genetics. Quart. J. Med. 92,223–232 (1999).
   Google Scholar
• Neugroschl J, Davis KL. Biological markers in Alzheimer's disease. Am. J.Geriat. Psych. 10(6), 660–677 (2002).
   Google Scholar